Kubota Pharmaceutical Holdings Co (TSE:4596) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
39 GF Score
Price 円65.00
GF Value 円16.38
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Kubota Pharmaceutical Holdings Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4596
39GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円65.00 is trading 296.8% above its estimated GF Value™ of 円16.38. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • FFO:
  • GF Value™: 円16.38 vs. price of 円65.00 (296.8% above fair value)
  • GF Score™: 39/100 with 1 warning sign

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
39GF Score

Get the complete analysis for TSE:4596

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円65.00
Price
円16.38
GF Value